Cell Bio Human Tech Co.,Ltd (KOSDAQ: A318160)
Materials · Chemicals · KR
₩6,980.00
+4.18% today · -13.6% 1Y
Cell Bio Human Tech Co.,Ltd (KOSDAQ: A318160) operates in the Chemicals industry within the Materials sector. The company is valued at $41.36M.
Over the last twelve months the share price has lost 13.6%, trading between 4.96K and 11.51K.
Tweenvest scores Cell Bio Human Tech Co.,Ltd across four factors: quality 67/100, value 63/100. Its strongest factor is quality.
A318160 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $41.36M
- Revenue (TTM)
- $36.48M
- P/E
- 6.31
- EPS
- 1,106.43
- Dividend yield
- —
- Beta (5Y)
- 0.11
- 52-week high
- ₩11,510.00
- 52-week low
- ₩4,960.00
- Avg volume (3M)
- —
- Shares outstanding
- 8.38M
- Employees
- —
- Next earnings
- —
Other Chemicals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Linde plcNasdaqGS: LIN | $225.89B | $490.03 | +0.50% |
| L'Air Liquide S.A.ENXTPA: AI | $124.55B | €167.70 | +0.35% |
| The Sherwin-Williams CompanyNYSE: SHW | $83.68B | $346.73 | +0.04% |
| Ecolab Inc.NYSE: ECL | $80.45B | $286.98 | +1.90% |
| Shin-Etsu Chemical Co., Ltd.TSE: 4063 | $70.74B | ¥6,051.00 | -1.79% |
| Air Products and Chemicals, Inc.NYSE: APD | $68.20B | $306.24 | +0.37% |
| Corteva, Inc.NYSE: CTVA | $55.25B | $82.81 | +1.25% |
| BASF SEXTRA: BAS | $52.67B | €52.43 | +1.47% |
Figures last refreshed Aug 18, 2026.